September 12, 2023
COLUMBUS, Ohio – Research funding at The Ohio State University College of Medicine experienced double-digit growth during the 2023 fiscal year setting a new record at $421.4 million.
Total research awards increased by 14.3% from $368.5 million in 2022. The National Institutes of Health, part of the U.S. Department of Health and Human Services, awarded the College of Medicine more than $237 million in grants, contracts and subcontracts. The remaining funding came from other government agencies, non-profit foundations and industry contracts.
“We’ve had another year of unprecedented growth in foundational research, translational and implementation sciences, community health, health services and clinical trials,” said Carol R. Bradford, MD, dean of the College of Medicine and vice president for Health Sciences at The Ohio State University Wexner Medical Center. “This accomplishment is a testament to the hard work, curiosity and commitment to research and innovation on the part of our faculty, learners and staff.”
Ohio State’s fiscal year 2023 research portfolio has 88 new awards over $1 million, including:
- A $8.4 million grant from the U.S. Department of Defense to study suicide prevention interventions for service members.
- A $4.3 million award from the American Heart Association to determine if exercise can protect against stress-induced heart disease.
- A $3.9 million grant from the U.S. Food and Drug Administration to study the effects of e-cigarette flavors on the smoking behaviors of current adult smokers.
In all, there are more than 3,100 active awards in fiscal year 2023.
The rise in funding comes after the College of Medicine moved up two spots to the 28th Best Medical School – Research and the 9th Best Public Medical School – Research, in the U.S. News & World Report 2024 “Best Medical Schools – Research” list.
“As a land-grant university, we are dedicated to creating and discovering knowledge to improve the well-being of our local, state, regional and national communities,” said Peter Mohler, PhD, acting university president and executive vice president for research, innovation and knowledge at The Ohio State University and chief scientific officer at Ohio State Wexner Medical Center. “This impressive funding increase reflects the talent of our researchers and the level of science in our laboratories. We are excited to push forward new discoveries to impact our communities.”
###
Media Contact: Serena Smith, Wexner Medical Center Media Relations, serena.smith@osumc.edu